Michel Lavit
Impact in
-
- Antibiotic Use and Resistance
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
Papers in
-
- Forensic Toxicology and Drug Analysis 4
-
- Antibiotic Resistance in Bacteria 5
- Co-authors
- Georges HouinSylvie SaivinB. GeorgesÉtienne ChatelutThierry SeguinPierre CanalLionel RostaingNassim Kamar
- Journals
- Transplant International (2 papers)International Journal of Antimicrobial Agents (2 papers)British Journal of Clinical Pharmacology (2 papers)Legal Medicine (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- FranceSwitzerlandBelgium
In The Last Decade
Michel Lavit
33 papers receiving 610 citations
Peers
Comparison fields: 5 of 97
- Applied Microbiology and Biotechnology 42
- Transplantation 54
- Molecular Medicine 71
- Pharmacology 186
- Toxicology 25
Countries citing papers authored by Michel Lavit
This map shows the geographic impact of Michel Lavit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Lavit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Lavit more than expected).
Fields of papers citing papers by Michel Lavit
This network shows the impact of papers produced by Michel Lavit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Lavit. The network helps show where Michel Lavit may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michel Lavit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 8 | |
| 2 | 2022 | 23 | |
| 3 | 2020 | 8 | |
| 4 | 2018 | 12 | |
| 5 | 2016 | 2 | |
| 6 | 2016 | 0 | |
| 7 | 2014 | 0 | |
| 8 | 2014 | 25 | |
| 9 | 2009 | 29 | |
| 10 | 2008 | 14 | |
| 11 | 2007 | 8 | |
| 12 | 2007 | 39 | |
| 13 | 2007 | 36 | |
| 14 | 2007 | 95 | |
| 15 | 2006 | 53 | |
| 16 | 2006 | 44 | |
| 17 | 2004 | 13 | |
| 18 | 2003 | 31 | |
| 19 | 1998 | 71 | |
| 20 | 1996 | 42 |
About Michel Lavit
Michel Lavit is a scholar working on Toxicology, Molecular Medicine, Applied Microbiology and Biotechnology, Emergency Medicine and Transplantation, having authored 36 papers that have together received 643 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Poisoning and overdose treatments (5 papers), Antibiotic Resistance in Bacteria (5 papers), Forensic Toxicology and Drug Analysis (4 papers), HIV/AIDS drug development and treatment (3 papers), Renal Transplantation Outcomes and Treatments (2 papers), Analytical Chemistry and Chromatography (2 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (42 citations), Transplantation (54 citations), Molecular Medicine (71 citations), Pharmacology (186 citations) and Toxicology (25 citations). Michel Lavit has collaborated with scholars based in France, Switzerland and Belgium. Frequent co-authors include Georges Houin, Sylvie Saivin, B. Georges, Étienne Chatelut, Thierry Seguin, Pierre Canal, Lionel Rostaing, Nassim Kamar, Peggy Gandia and Olivier Cointault. Their work appears in journals such as Transplant International, International Journal of Antimicrobial Agents, British Journal of Clinical Pharmacology, Legal Medicine and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.